Immune System News and Research

RSS

Researchers discover that DNA fragments destroy melanoma cells

Researchers at Boston University School of Medicine have discovered that small DNA fragments or oligonucleotides that resemble the telomere (chromosome end), also called T-oligos, can cause human melanoma cells to undergo extensive apoptosis (cell death), while surviving melanoma cells become more differentiated and therefore less aggressive.

1 Sep 2004

International research sheds light on Escherichia coli

An unprecedented picture of how bacteria latch on to human cells has been published by UK, French and US scientists. They have produced a finely detailed model of one of the tools used by some of the nastiest varieties of the stomach bug, Escherichia coli, to stick to and gain entry to host cells.

1 Sep 2004

Parental human leukocyte antigen genes linked to preterm delivery

The transmission of Human Leukocyte Antigen (HLA) genes may play a significant role in the risk of preterm delivery, according to a study in the September issue of Obstetrics and Gynecology.

31 Aug 2004

Epimmune presents SIV vaccine study data showing control of virus despite the presence of viral mutations

Epimmune today presented preliminary data from its ongoing SIV rhesus macaque vaccine study at the AIDS Vaccine 2004 conference in Lausanne, Switzerland.

31 Aug 2004

Young adults ate and smoked more in the 1990s

Young adults, apparently believing they are immune from risk, had large increases in smoking and obesity and had continued poor eating habits during the 1990s, according to surveys of more than 120,000 people.

31 Aug 2004

Major trends in AIDS research that the different research teams throughout the world are pursuing

The science will be presented during the conference which is taking place in Lausanne until September 1, 2004. The advances in fundamental research, notably through a better understanding of the complex processes of immune defence, HIV and the functioning of vaccines, promote the genesis and development of new vaccine candidates.

30 Aug 2004

Interim data from human clinical trials of two AIDS vaccine candidates, named DNA.HIVA and MVA.HIVA

The interim data, from 205 volunteers in clinical trials in Kenya, Uganda and the United Kingdom, show that DNA.HIVA and MVA.HIVA are generally safe and well tolerated. However, the candidates’ ability to elicit an anti-HIV cell-mediated immune response is poor, using currently accepted measures of immune response.

30 Aug 2004

Scientists discover breakthrough method to treat neuronal diseases

What do stroke, epilepsy, head or spinal cord trauma, Parkinson’s disease and Alzheimer’s disease patients have in common? They all suffer from neuronal cell death brought about by the absence or malfunction of specific genes.

30 Aug 2004

Common enzyme acts as a natural brake to prevent potentially deadly runaway inflammation

An enzyme found in nearly all animal and human cells acts as a natural brake to prevent potentially deadly runaway inflammation, UCSF scientists have discovered.

30 Aug 2004

Streptococcal bacteria disrupts blood clotting to infect humans

University of Michigan researchers have captured a glimpse of the endless arms race between infectious agents and the human immune system in a bacterium that uses a mimic of a human blood-clotting enzyme to advance its infection.

27 Aug 2004

Solid evidence that best treatment for multiple sclerosis is pregnancy

For years, doctors have suggested the best treatment for multiple sclerosis is pregnancy. Now, an Oregon study is delivering solid evidence to support the theory.

27 Aug 2004

Day care or nursery school attendance may reduce risk of developing Hodgkin's disease

Young adults who attended day care or nursery school when they were children were more than a third less likely to develop Hodgkin's disease, according to a new study by Harvard School of Public Health researchers.

25 Aug 2004

High-resolution images reveal the molecular rearrangements that rotavirus uses to break into cells

High-resolution images constructed by researchers at Children's Hospital Boston and Harvard Medical School reveal the molecular rearrangements that rotavirus – the most common cause of severe, dehydrating diarrhea and vomiting in children worldwide – uses to break into cells.

25 Aug 2004

Australian research giant begins trial of avian influenza vaccine

The trial vaccine utilises Imugene Limited's platform adenoviral vector technology to deliver the necessary genetic material to stimulate the birds' immune responses.

25 Aug 2004

Regular exercise boosts immune system in older men

As it turns out, judging by the reaction strength of their immune system to an unknown, but harmless, protein antigen, it’s possible for men over 70 to mount an immune response similar to that produced by much younger men -- if they get regular moderate physical activity of about six hours a week.

25 Aug 2004

Researchers find how cancers, particularly lymphomas, develop and might be prevented

Researchers at Children's Hospital Boston have begun unraveling the mystery of how B lymphocytes - key infection-fighting cells in the body - are able to create many different kinds of specialized antibodies through selective gene mutations, while being protected from random mutations that could give rise to cancers.

23 Aug 2004

Surprise finding could lead to hepatitis C vaccine

New research from the University of New South Wales shows some people may repeatedly be able to clear hepatitis C virus from their bodies, without any biological traces of the potentially serious infection.

23 Aug 2004

New information about how HIV evades eradication from the body

Researchers at the National Cancer Institute, have discovered new information about how human immunodeficiency virus (HIV), the virus that causes acquired immune deficiency (AIDS), possibly evades eradication from the body.

23 Aug 2004

Effect of prebiotic and probiotic foods on health

A group of researchers at the Public University of Navarre, led by Senior Lecturer in Zoology, Elena Urdaneta Artola, have studied both the mechanisms whereby foodstuffs known as functional act at a gastrointestinal level as well as their possible beneficial effects on the health of individuals.

23 Aug 2004

Manitoba's first human case of West Nile virus infection

The first human case of West Nile virus infection this year has been identified in Manitoba. The individual, a Winnipeg resident in his sixties, is currently in hospital. The individual has been reported to Health Canada as a probable case of West Nile neurological syndrome.

20 Aug 2004

Immune System News and Research

Researchers discover that DNA fragments destroy melanoma cells

International research sheds light on Escherichia coli

Parental human leukocyte antigen genes linked to preterm delivery

Epimmune presents SIV vaccine study data showing control of virus despite the presence of viral mutations

Young adults ate and smoked more in the 1990s

Major trends in AIDS research that the different research teams throughout the world are pursuing

Interim data from human clinical trials of two AIDS vaccine candidates, named DNA.HIVA and MVA.HIVA

Scientists discover breakthrough method to treat neuronal diseases

Common enzyme acts as a natural brake to prevent potentially deadly runaway inflammation

Streptococcal bacteria disrupts blood clotting to infect humans

Solid evidence that best treatment for multiple sclerosis is pregnancy

Day care or nursery school attendance may reduce risk of developing Hodgkin's disease

High-resolution images reveal the molecular rearrangements that rotavirus uses to break into cells

Australian research giant begins trial of avian influenza vaccine

Regular exercise boosts immune system in older men

Researchers find how cancers, particularly lymphomas, develop and might be prevented

Surprise finding could lead to hepatitis C vaccine

New information about how HIV evades eradication from the body

Effect of prebiotic and probiotic foods on health

Manitoba's first human case of West Nile virus infection

Understanding the DNA Damage Response in Innate Immunity eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News